Contributor Page
Norton Rose Fulbright Canada LLP
 
Email  |  Website  |  Articles
Contact Details
Tel: +1 416 2164000
Fax: +1 416 2163930
Suite 3800
Royal Bank Plaza, South Tower
200 Bay Street, P.O. Box 84
Toronto
Ontario
M5J 2Z4
Canada
Awards
Contributor Most Read
Contributor Most Read
By Karen Jensen
Chodha v. 1352866, 2016 HRTO 1241 demonstrates that human rights tribunals will consider an employer's bona fide subjective belief in deciding whether the employer has provided a reasonable explanation...
By Troy Ungerman
The entity must also have qualified cybersecurity personnel who are trained in addressing cybersecurity risks.
By Sara Josselyn
Yesterday, Budget 2017 was tabled by the Liberal government. While Budget 2016 contained many significant tax changes, Budget 2017 does not.
By William Armstrong, QC
The Alberta government recently announced it would review Alberta's workplace laws, including the Labour Relations Code and the Employment Standards Code.
By Dominic Belley, Jules Charette, Derek Chiasson, Len Farber, Sébastien Gingras, Adrienne Oliver, Dion Legge, Barry Segal, Darren Hueppelsheuser, Catherine Brayley, Chris Speakman
Much ado about nothing. Budget 2017 was tabled today by the Liberal government. While Budget 2016 contained many significant tax changes, Budget 2017 does not.
By Kevin Ackhurst, Stephen Nattrass
The Competition Bureau recently cleared the proposed acquisition of Canexus Corporation by Chemtrade Logistics Income Fund despite concluding that the transaction was likely to result in a substantial lessening or prevention of competition.
By Jonathan Chong, Allyson Whyte Nowak, Judith Robinson
On March 13, 2017, Apotex filed for leave to appeal the Federal Court of Appeal's (FCA) decision addressing validity and infringement of AstraZeneca's Canadian Patent No. 1,292,693 (the 693 Patent) (reported here) with the Supreme Court of Canada (SCC).
By Kevin Ackhurst, D. Michael Brown, Danny Urquhart
Plaintiffs in follow-on competition law class actions routinely seek information from Canada's Competition Bureau in aid of their actions.
By Sara Josselyn
As we reported in 2014, United States post-deal litigation became more of a rule than an exception in the early-to-mid 2010s, with over 95% of M&A transactions attracting litigation.
By Jullian Hyslop, Sara Zborovski
Health Canada recently released for consultation the Draft Guidance Document – Administrative Processing of Submissions and Applications Involving Human or Disinfectant Drugs.
By Alan Harvie
Alberta recently announced that for the 2018 compliance year under the Specified Gas Emitters Regulation (SGER) it will limit the use of carbon credits to 30% of a regulated entity's compliance obligations.
By Pierre T. Nguyen
Après un long hiver, l'hivernation se termine – ainsi que ma charge de cours qui a pris un gros morceau de mes temps libres (…) et de rédaction pour les Actifs Créatifs.
By William Armstrong, QC
On March 13, 2017, the Alberta government announced that they would be proceeding with a review of Alberta's workplace laws, including the Labour Relations Code and the Employment Standards Code.
By Michael Torrance
In January of 2017 the Ontario Ministry of Labour issued a clarifying statement on the definition of a Critical Injury under Regulation 834 of the Occupational Health and Safety Act.
By David Yi, Allyson Whyte Nowak, Randy Sutton, Rahool Agarwal
Abbott Laboratories Limited, Takeda Pharmaceuticals Company Limited and Takeda Pharmaceuticals America Inc. (collectively, the Defendants) sought summary judgment of Apotex Inc.'s action for damages pursuant to section 8 of the Regulations.
Contributor's Topics
More...